D
Crinetics Pharmaceuticals, Inc. CRNX
$34.47 -$0.57-1.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -74.11% -78.00% -71.35% -53.93% -15.28%
Total Other Revenue -- -- -- -- --
Total Revenue -74.11% -78.00% -71.35% -53.93% -15.28%
Cost of Revenue 42.50% 37.03% 35.80% 30.59% 29.41%
Gross Profit -45.35% -40.53% -39.42% -33.25% -31.10%
SG&A Expenses 71.68% 69.51% 60.53% 45.46% 37.03%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 49.98% 45.04% 41.92% 34.25% 31.28%
Operating Income -52.22% -47.84% -44.78% -36.33% -32.60%
Income Before Tax -39.10% -39.36% -40.59% -34.33% -30.88%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -39.10% -39.36% -40.59% -34.33% -30.88%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -39.10% -39.36% -40.59% -34.33% -30.88%
EBIT -52.22% -47.84% -44.78% -36.33% -32.60%
EBITDA -51.72% -47.54% -44.68% -36.39% -32.72%
EPS Basic -0.12% -2.14% -10.61% -15.15% -17.50%
Normalized Basic EPS -0.11% -2.14% -10.62% -15.15% -17.50%
EPS Diluted -0.23% -2.25% -10.73% -15.27% -17.34%
Normalized Diluted EPS -0.11% -2.14% -10.62% -15.15% -17.50%
Average Basic Shares Outstanding 39.09% 36.42% 27.56% 17.04% 11.69%
Average Diluted Shares Outstanding 39.09% 36.42% 27.56% 17.04% 11.69%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings